HALO logo
halo search icon
Cellectis S.A. Sponsored ADR

US$3.66

Price Change Indicator
0.03 (0.826%)
Cellectis S.A. Sponsored ADR
CLLS · NAS

Cellectis S.A. Sponsored ADR

Start Trading CLLS for Free

US$3.66

Price Arrow0.03 (0.826%)
20/05/2026 04:00:00 PM
All-ConsensusEngulfing BullishEngulfing Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cellectis S.A. Sponsored ADR Overview

CLLS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CLLS

icon
icon

Telephone

33.1.81.69.16.00

icon

Address

8, rue de la Croix Jarry, Paris, Ile-de-France 75013

Description

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

CLLS Price Chart

Key Stats

Market Cap

US$271.58M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.33 - 5.48

Trade Value (12mth)

US$85,754.00

1 week

-7.4%

1 month

-9.25%

YTD

-24.38%

1 year

138.82%

All time high

50.00

Key Fundamentals

EPS 3 yr Growth

-71.00%

EBITDA Margin

-27.80%

Operating Cashflow

-$40m

Free Cash Flow Return

-20.40%

ROIC

-34.40%

Interest Coverage

-2.50

Quick Ratio

1.60

Other Data

Shares Outstanding (Fully Diluted)

101m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CLLS Announcements

Latest Announcements

DateAnnouncements
21 May 26
12 May 26
12 May 26
12 May 26
05 May 26

CLLS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.78-0.41-0.68locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.78-0.41-0.68locklocklock
Growth
 %locklocklocklock23.977.2-66.9locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cellectis S.A. Sponsored ADR (CLLS:NAS)?
Halo FAQ
The current share price of Cellectis S.A. Sponsored ADR (CLLS:NAS) is USD$3.66.
What is the 52-week high share price for Cellectis S.A. Sponsored ADR (CLLS:NAS)?
Halo FAQ
The 52-week high share price for Cellectis S.A. Sponsored ADR (CLLS:NAS) is USD$5.48.
What is the 52-week low share price for Cellectis S.A. Sponsored ADR (CLLS:NAS)?
Halo FAQ
The 52-week low share price for Cellectis S.A. Sponsored ADR (CLLS:NAS) is USD$1.33.
What is the dividend yield for Cellectis S.A. Sponsored ADR (CLLS:NAS)?
Halo FAQ
Cellectis S.A. Sponsored ADR (CLLS:NAS) does not pay a dividend.
What was Cellectis S.A. Sponsored ADR (CLLS:NAS) last dividend payment?
Halo FAQ
Cellectis S.A. Sponsored ADR (CLLS:NAS) does not pay a dividend.
What is the franking level for Cellectis S.A. Sponsored ADR (CLLS:NAS)?
Halo FAQ
Cellectis S.A. Sponsored ADR (CLLS:NAS) has a franking level of 0.00%.
In which sector is Cellectis S.A. Sponsored ADR (CLLS:NAS) classified?
Halo FAQ
Cellectis S.A. Sponsored ADR (CLLS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial